The business case for the VTE service
A robust business case can be made for the VTE service and the coronavirus pandemic has further demonstrated the value of the service, according to Mr Kieron Power; […]
A robust business case can be made for the VTE service and the coronavirus pandemic has further demonstrated the value of the service, according to Mr Kieron Power; […]
Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist […]
Recurrence of venous thrombo-embolism (VTE) may be more common than people think and 30% of people develop post thrombotic syndrome, according to Mr Kieron Power; Lead Pharmacist – […]
Specialist pharmacists are now the primary clinicians who look after patients with venous thromboembolism (VTE) at Singleton Hospital in Swansea. IMI spoke to Mr Kieron Power, Clinical Lead […]
Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by £139 million, according to a study published in […]
Drs Claire Scullin and Joanne Brown describes how prescribing pharmacists will carry out in-depth medication reviews for hospital inpatients and make any changes needed to prescriptions as part […]
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]
The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and effectiveness of ivermectin, according to Dr […]
The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. https://www.youtube.com/watch?v=T67szXgTqWw&ab_channel=MedicalUpdateOnline […]
Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]
Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]
Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]